ProShare Advisors LLC Buys 589,787 Shares of Albemarle Corporation $ALB

Posted by Geri Gentry on Nov 1st, 2026

ProShare Advisors LLC boosted its position in Albemarle Corporation (NYSE:ALB – Free Report) by 69.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,436,117 shares of the specialty chemicals company’s stock after acquiring an additional 589,787 shares during the period. ProShare Advisors LLC owned 1.22% of Albemarle worth $151,912,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Primecap Management Co. CA acquired a new position in Albemarle in the second quarter valued at about $358,101,000. Deutsche Bank AG bought a new position in shares of Albemarle during the second quarter worth about $131,049,000. Bank of New York Mellon Corp bought a new stake in Albemarle in the 2nd quarter valued at approximately $103,268,000. Robeco Institutional Asset Management B.V. lifted its stake in Albemarle by 2,981.1% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 733,793 shares of the specialty chemicals company’s stock valued at $77,621,000 after acquiring an additional 709,977 shares in the last quarter. Finally, Nykredit A S acquired a new position in Albemarle during the 2nd quarter worth approximately $78,121,000. 92.87% of the stock is owned by institutional investors.

Albemarle Stock Performance

ALB opened at $91.00 on Friday. The company has a quick ratio of 1.35, a current ratio of 2.09 and a debt-to-equity ratio of 0.22. Albemarle Corporation has a 12-month low of $88.01 and a 12-month high of $221.00. The business has a 50 day moving average of $111.88 and a 200-day moving average of $149.82. The stock has a market cap of $10.74 billion, a price-to-earnings ratio of 337.05, a PEG ratio of 0.54 and a beta of 1.36.

Albemarle (NYSE:ALB – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The specialty chemicals company reported $3.75 EPS for the quarter, beating the consensus estimate of $3.20 by $0.55. The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.61 billion. Albemarle had a net margin of 3.09% and a return on equity of 10.96%. The company’s quarterly revenue was up 31.1% on a year-over-year basis. During the same period in the previous year, the company earned $0.11 earnings per share. On average, equities research analysts expect that Albemarle Corporation will post 11.15 earnings per share for the current year.

Albemarle Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Friday, December 18th will be given a $0.41 dividend. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Friday, December 18th. Albemarle’s payout ratio is presently 607.41%.

Analyst Ratings Changes

ALB has been the topic of a number of recent research reports. Weiss Ratings downgraded shares of Albemarle from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, October 23rd. Scotiabank reduced their target price on shares of Albemarle from $200.00 to $190.00 and set a “sector outperform” rating for the company in a report on Monday, August 10th. Mizuho raised shares of Albemarle from a “neutral” rating to an “outperform” rating and set a $130.00 target price for the company in a research report on Wednesday, October 14th. JPMorgan Chase & Co. lowered their price target on shares of Albemarle from $160.00 to $140.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 25th. Finally, Wall Street Zen raised shares of Albemarle from a “hold” rating to a “buy” rating in a research report on Saturday, October 10th. Fifteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Albemarle presently has an average rating of “Hold” and a consensus price target of $179.41.

Read Our Latest Stock Analysis on ALB

Albemarle Company Profile

(Free Report)

Albemarle Corporation (NYSE: ALB) is a global specialty chemicals company headquartered in Charlotte, North Carolina. The company develops, manufactures, and markets engineered chemicals used in energy storage, transportation, refining, pharmaceuticals, agriculture, consumer products, and other industrial applications.

Albemarle is one of the world’s major producers of lithium and supplies lithium compounds, including lithium carbonate and lithium hydroxide, for use in rechargeable batteries for electric vehicles, portable electronics, and grid energy-storage systems.